Articles On Medibio (ASX:MEB)

Benchmark index falls on Monday, closing out the day down 0.21% Utilities and Materials sectors edge higher, but Health Care anchors the benchmark into the red Small caps led by Galileo Mining, Infinity and last week’s rockstar Biotron...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

The ASX 200 benchmark falls 0.5% as central bank boogeymen spook investors Energy pretty much on its own out front of the rest of the sectors Small caps led by lithium and new metal minnows with some sturdy new finds   Local markets hav...

Stockhead’s Top 10 at shortly-before-11-ish, published once I’ve had a chance to make sense of who’s going where, and for what reason, which is harder than it sounds because sometimes things just move on their own, like there’s a poltergeis...

ASX 200 ends sharply lower on Monday, down 0.67% All Sectors  close in the red, with InfoTech taking the worst of the damage Small caps led by lithium minnows RR1, WC8 and VCM Australian shares have joined most Asian markets in a retre...

ASX 200 closes 0.46% higher after building up slowly all day Uranium goes off. Materials, Finance Sectors call the shots Small caps led by an all uranium cast, including   Australian shares have been lifted despite a mixed overnight lea...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

ASX 200 falls sharply from the open, tracking Wall St sell off ahead of US CPI read tonight Most sectors decline led by Tech and Industrials Tempus Resources jumps 50%, cops a speeding ticket   Australian shares stepped off the into th...

ASX200 ends choppy day 0.2% higher Miners and med stocks offset banks and Energy  Small caps led by NickelSearch, Odin   All shook up, but home alive – Aussie shares somehow brought home the bacon on Tuesday, with both the All Ords and...

ASX 200 closes strongly on China data and iron ore futures after weak start Banks, Miners and Staples offset losses for Healthcare and IT Sectors Small caps led by CNW, OMX   Australian shares failed to launch before lunch on Monday, bu...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

  ASX 200 closes -0.25% lower after RBA holds rates at 4.10% Only Consumer Staples, Healthcare and Industrial Sectors find some green Small caps dominated by Torque Metals   Aussie home owners have been given another month of grace time f...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

ASX 200 benchmark ends almost 0.4% lower Only Consumer Discretionary and Energy Sectors rise Small cap stocks led by exploration minnow Western Gold Resources (ASX:WGR)   How to spin this for a gentler end to Monday…? Well, it’s not been...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Local markets have pedalled furiously since lunch to bring the benchmark to +0.35%. CBA posts record $10.2 billion profit off the back of ever-increasing interest rates. Small capper Perpetual stuns with a 50% spike after buying up land in...

ASX benchmark finishes the flat, after struggling to find traction since mid-morning Health Care romped home to win Best Sector today, up more than 0.4% Errawarra’s nearology has continued to pay off, adding around 50% more today.   Whil...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Medibio (ASX:MEB) says it has received firm commitments to raise $2.25 million through the issue of new fully paid ordinary shares.

ASX sleepwalks to an underwhelming -0.3% loss for the day.  Real Estate the ‘highlight’, on a paltry +0.5% Lithium Australia’s tech-for-facilities deal with MinRes saw it climb past +80% for the session.   It’s been a weak and sorry day o...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

The ASX 200 has had its worst day in roughly a month with a 1.29 percentage dip  The sectors were a shade of spilt claret, with Utilities and Real Estate leading losses Standout small caps: BCAL Diagnostics and American West Metals   Loca...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX couldn’t make up its mind, a bit like economists looking ahead to the RBA decision tomorrow. Health Care and Industrials Stocks had a day to savour, while Staples and IT largely did not. Some standout small caps: TALi Digital, Ecof...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 had another fine day, ending with a 0.73% gain overall Sectors wise, Tech and Real Estate were the winners, while Materials dipped as a whole, partly due to Rio and Fortescue  Standout small-cap performers: R3D, PAC, and the ju...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Medibio jumps after completing Phase 1 clinical trial Cann Group’s latest crop harvest is at a scale twice that of previous harvests 4DMedical wins a $1.1 million from the Fed government   Microcap Medibio (ASX:MEB) jumped 50% this mornin...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX is set to open higher on Monday after a modest rise on Wall Street US stocks to report earnings include American Express and Chevron A big week ahead for markets as the Fed and ECB will hand down rates decisions   Local shares are...

The ASX banks another dim result, down 0.4% for the day Materials recovered from an early slump, but InfoTech powered on to help minimise losses Metal Hawk’s TREO find at Fraser South was the day’s true highlight; stock up 140% as a result...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

S&P/ASX 200 closes up 0.35% ending three day losing streak, Emerging Companies index up .10% Limeade surges more than 300% after announcing $112 million takeover by by US-based Web Health Services MQR and MinRes accelerate their farm-i...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Aussie markets ended the day 0.16% lower, because someone raised interest rates yesterday Investors are running back into the safe haven arms of the goldies, while the tech sector shines Two little Small Cappers made triple-digit gains tod...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

The S&P ASX 200 was down 2.5% in May, with mid caps performing the best and small caps lagging blue chips The S&P ASX 200 Information Technology sector performed the best in May, up 11.6% following strong AI interest Wildcat Resou...

The ASX 200 rose 0.30%, as the day turned out flattish to half decent, rather than deadset flattened The fact US Congress types look like reaching a debt-ceiling deal no doubt helped matters Healthcare and tech stonks are up, while Paladin...

ASX benchmark ends the day flat, but not for lack of trying to rise. Or fall Tech stocks fell hard at first light, but rallied to finish the day well out in front Despite a short-lived challenge from Audio Pixels, Micro-X has won the day i...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

The ASX 200 benchmark waddled its way to a regrettable 0.45% end to the day Materials the only sector to close on a positive note, up 0.22% Power Minerals wins the day with a canny move from copper-gold to lithium   There wasn’t a whole l...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

S&P/ASX 200 closes flat up just 0.07%, while the emerging companies index falls 0.48% Cellnet Group up 44% after a takeover bid by German private company Wentronic Holding GmbH Podium Minerals completes $2 million cap raise to advance...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...